Literature DB >> 23404293

Loss of the oligosaccharyl transferase subunit TUSC3 promotes proliferation and migration of ovarian cancer cells.

Petr Vaňhara1, Peter Horak, Dietmar Pils, Mariam Anees, Michaela Petz, Wolfgang Gregor, Robert Zeillinger, Michael Krainer.   

Abstract

Consequences of deregulated protein N-glycosylation on cancer pathogenesis are poorly understood. TUSC3 is a gene with a putative function in N-glycosylation, located on the short arm of chromosome 8. This is a chromosomal region of frequent genetic loss in ovarian cancer. We established recently that the expression of TUSC3 is epigenetically decreased in epithelial ovarian cancer compared to benign controls and provides prognostic information on patient survival. Therefore, we analyzed the consequences of silenced TUSC3 expression on proliferation, invasion and migration of ovarian cell lines. In addition, we performed subcellular fractionation, co-immunofluorescence and co-immunoprecipitation experiments to establish the molecular localization of TUSC3 in ovarian cancer cells. We demonstrated that TUSC3 is localized in the endoplasmic reticulum as a subunit of the oligosaccharyltransferase complex and is capable of modulation of glycosylation patterning of ovarian cancer cells. Most importantly, silencing of TUSC3 enhances proliferation and migration of ovarian cancer cells in vitro. Our observations suggest a role for N-glycosylating events in ovarian cancer pathogenesis in general, and identify TUSC3 as a tumor suppressor gene in ovarian cancer in particular.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23404293     DOI: 10.3892/ijo.2013.1824

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  20 in total

Review 1.  X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia disease: a combined immune deficiency with magnesium defect.

Authors:  Juan Ravell; Benjamin Chaigne-Delalande; Michael Lenardo
Journal:  Curr Opin Pediatr       Date:  2014-12       Impact factor: 2.856

Review 2.  TUSC3: functional duality of a cancer gene.

Authors:  Kateřina Vašíčková; Peter Horak; Petr Vaňhara
Journal:  Cell Mol Life Sci       Date:  2017-09-19       Impact factor: 9.261

3.  TUSC3 suppresses glioblastoma development by inhibiting Akt signaling.

Authors:  Zhenfeng Jiang; Mian Guo; Xiangtong Zhang; Lifen Yao; Jia Shen; Guizhen Ma; Li Liu; Liwei Zhao; Chuncheng Xie; Hongsheng Liang; Haiyang Wang; Minwei Zhu; Li Hu; Yuanyuan Song; Hong Shen; Zhiguo Lin
Journal:  Tumour Biol       Date:  2016-05-13

4.  UHRF1-KAT7-mediated regulation of TUSC3 expression via histone methylation/acetylation is critical for the proliferation of colon cancer cells.

Authors:  Kenzui Taniue; Tomoatsu Hayashi; Yuki Kamoshida; Akiko Kurimoto; Yasuko Takeda; Lumi Negishi; Kei Iwasaki; Yoshifumi Kawamura; Naoki Goshima; Tetsu Akiyama
Journal:  Oncogene       Date:  2019-10-03       Impact factor: 9.867

5.  Effects of RNAi-mediated TUSC3 silencing on radiation-induced autophagy and radiation sensitivity of human lung adenocarcinoma cell line A549 under hypoxic condition.

Authors:  Ya-Guang Li; Nai-Xin Liang; Ying-Zhi Qin; Dong-Jie Ma; Chang-Jin Huang; Lei Liu; Shan-Qing Li
Journal:  Tumour Biol       Date:  2016-11-30

6.  Genomic alterations on 8p21-p23 are the most frequent genetic events in stage I squamous cell carcinoma of the lung.

Authors:  Jiun Kang
Journal:  Exp Ther Med       Date:  2014-12-09       Impact factor: 2.447

7.  Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and Metastasis.

Authors:  Xiaoqiang Fan; Xiu Zhang; Jie Shen; Haibin Zhao; Xuetao Yu; Yong'an Chen; Zhuonan Zhuang; Xiaolong Deng; Hua Feng; Yunfei Wang; Long Peng
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

Review 8.  TUSC3: a novel tumour suppressor gene and its functional implications.

Authors:  Xinshuang Yu; Chunjuan Zhai; Yujun Fan; Jiandong Zhang; Ning Liang; Fengjun Liu; Lili Cao; Jia Wang; Juan Du
Journal:  J Cell Mol Med       Date:  2017-03-08       Impact factor: 5.310

9.  TUSC3 loss alters the ER stress response and accelerates prostate cancer growth in vivo.

Authors:  Peter Horak; Erwin Tomasich; Petr Vaňhara; Kateřina Kratochvílová; Mariam Anees; Maximilian Marhold; Christof E Lemberger; Marion Gerschpacher; Reinhard Horvat; Maria Sibilia; Dietmar Pils; Michael Krainer
Journal:  Sci Rep       Date:  2014-01-17       Impact factor: 4.379

10.  TUSC3 induces autophagy in human non-small cell lung cancer cells through Wnt/β-catenin signaling.

Authors:  Yun Peng; Jun Cao; Xiao-Yi Yao; Jian-Xin Wang; Mei-Zuo Zhong; Ping-Ping Gan; Jian-Huang Li
Journal:  Oncotarget       Date:  2017-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.